APOA1 and chronic hepatitis: This study first aimed to verifying that the ApoB/ApoA1 ratio is strongly correlated with CHB disease progression, and its predictive potential is not correlated with potential risk factors (e.g., age, anti-hepatitis treatment, and duration of chronic hepatitis).